Release Date: 02/04/15 09:14 Summary: Notice of Mar 2015 Quarter Results Release & Teleconference Price Sensitive: No Download Document 14.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%